Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

The memo said the Trump administration would “give preference to communities with marriage and birth rates higher than the ...

The man who hopes to be President Donald Trump’s health secretary said he needed to see data showing vaccines are safe, but ...

Between 2012 and 2018, there was a 34.6% increase in the occurrence of mental health diagnoses among children ages 4 to 17, ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...